SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Kirkegaard P.)
 

Search: WFRF:(Kirkegaard P.) > Liver transplantati...

Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy

Brandsaeter, B. (author)
Karolinska Institutet
Isoniemi, H. (author)
Broome, U. (author)
show more...
Olausson, Michael, 1956 (author)
Gothenburg University,Göteborgs universitet,Institutionen för de kirurgiska disciplinerna, Avdelningen för kirurgi,Institute of Surgical Sciences, Department of Surgery
Backman, L. (author)
Hansen, B. (author)
Schrumpf, E. (author)
Oksanen, A. (author)
Ericzon, B. G. (author)
Hockerstedt, K. (author)
Makisalo, H. (author)
Kirkegaard, P. (author)
Friman, Styrbjörn, 1948 (author)
Gothenburg University,Göteborgs universitet,Institutionen för de kirurgiska disciplinerna, Avdelningen för kirurgi,Institute of Surgical Sciences, Department of Surgery
Bjoro, K. (author)
show less...
 (creator_code:org_t)
Elsevier BV, 2004
2004
English.
In: Journal of hepatology. - : Elsevier BV. - 0168-8278. ; 40:5, s. 815-22
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • BACKGROUND/AIMS: Hepatobiliary malignancies are frequently seen in primary sclerosing cholangitis (PSC) and they complicate the evaluation of patients and timing of liver transplantation. METHODS: Data from all Nordic PSC patients listed for liver transplantation during 1990-2001 were recorded prospectively. Predictors of hepatobiliary malignancy and patient survival rates have been analysed. RESULTS: Hepatobiliary malignancy was found in 52/255 (20%) patients accepted to the waiting list. Recent diagnosis of PSC, no ursodeoxycholic acid (UDCA) treatment, clinical suspicion and previous colorectal-cancer were predictors of malignancy. Among 89 patients with a strong suspicion of malignancy prior to acceptance, 35 (39%) had confirmed malignancy. A clinical suspicion had been raised in 35/52 (67%) patients with malignancy. Malignancy was found in 31/223 patients who received a liver allograft. The 1-, 3- and 5-year patient survival rates following transplantation for patients with PSC and cholangiocarcinoma were 65, 35 and 35%, respectively. CONCLUSIONS: Hepatobiliary malignancy is suspected in 1/3 of the PSC patients and found in 1/5. Although cholangiocarcinoma is regarded as a contraindication to liver transplantation (LTX), PSC patients with cholangiocarcinoma had a 35% 5-year survival following transplantation.

Keyword

Adult
Biliary Tract Neoplasms/*complications
Carcinoma
Hepatocellular/complications
Cholangiocarcinoma/complications
Cholangitis
Sclerosing/*complications/mortality/*surgery
Colorectal Neoplasms/complications
Female
Gallbladder Neoplasms/complications
Humans
Liver Neoplasms/*complications
*Liver Transplantation/contraindications
Male
Middle Aged
Prognosis
Survival Rate

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view